Impact of Switching From a Vitamin K Antagonist to Rivaroxaban on Satisfaction With Anticoagulation Therapy: The XANTUS-ACTS Substudy.
about
Rivaroxaban in patients with atrial fibrillation: from ROCKET AF to everyday practice.Comparative effectiveness of rivaroxaban in the treatment of nonvalvular atrial fibrillation.Role of rivaroxaban in the management of atrial fibrillation: insights from clinical practice.Satisfaction with oral anticoagulants in patients with atrial fibrillation.
P2860
Impact of Switching From a Vitamin K Antagonist to Rivaroxaban on Satisfaction With Anticoagulation Therapy: The XANTUS-ACTS Substudy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Impact of Switching From a Vit ...... apy: The XANTUS-ACTS Substudy.
@en
Impact of Switching From a Vit ...... apy: The XANTUS-ACTS Substudy.
@nl
type
label
Impact of Switching From a Vit ...... apy: The XANTUS-ACTS Substudy.
@en
Impact of Switching From a Vit ...... apy: The XANTUS-ACTS Substudy.
@nl
prefLabel
Impact of Switching From a Vit ...... apy: The XANTUS-ACTS Substudy.
@en
Impact of Switching From a Vit ...... apy: The XANTUS-ACTS Substudy.
@nl
P2093
P2860
P356
P1433
P1476
Impact of Switching From a Vit ...... rapy: The XANTUS-ACTS Substudy
@en
P2093
A John Camm
Alexander G G Turpie
Craig I Coleman
Pierre Amarenco
Silvia Kuhls
Susanne Hess
Sylvia Haas
Thomas Evers
XANTUS Investigators
P2860
P304
P356
10.1002/CLC.22565
P577
2016-06-30T00:00:00Z